Vaxcyte Stock Price Prediction
| PCVX Stock | USD 94.34 0.36 0.38% |
Oversold Vs Overbought
21
Oversold | Overbought |
EPS Estimate Next Quarter (1.22) | EPS Estimate Current Year (3.96) | EPS Estimate Next Year (4.82) | Wall Street Target Price 151.75 | EPS Estimate Current Quarter (1.13) |
Using Vaxcyte hype-based prediction, you can estimate the value of Vaxcyte from the perspective of Vaxcyte response to recently generated media hype and the effects of current headlines on its competitors.
Vaxcyte Hype to Price Pattern
Investor biases related to Vaxcyte's public news can be used to forecast risks associated with an investment in Vaxcyte. The trend in average sentiment can be used to explain how an investor holding Vaxcyte can time the market purely based on public headlines and social activities around Vaxcyte. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Vaxcyte's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Vaxcyte.
The fear of missing out, i.e., FOMO, can cause potential investors in Vaxcyte to buy its stock at a price that has no basis in reality. In that case, they are not buying Vaxcyte because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Vaxcyte after-hype prediction price | USD 93.75 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Vaxcyte |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vaxcyte's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Vaxcyte After-Hype Price Prediction Density Analysis
As far as predicting the price of Vaxcyte at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Vaxcyte or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Vaxcyte, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Vaxcyte Estimiated After-Hype Price Volatility
In the context of predicting Vaxcyte's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Vaxcyte's historical news coverage. Vaxcyte's after-hype downside and upside margins for the prediction period are 91.54 and 95.96, respectively. We have considered Vaxcyte's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Vaxcyte is very steady at this time. Analysis and calculation of next after-hype price of Vaxcyte is based on 3 months time horizon.
Vaxcyte Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Vaxcyte is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Vaxcyte backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Vaxcyte, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.22 | 2.21 | 0.59 | 0.03 | 10 Events / Month | 2 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
94.34 | 93.75 | 0.63 |
|
Vaxcyte Hype Timeline
Vaxcyte is at this time traded for 94.34. The entity has historical hype elasticity of -0.59, and average elasticity to hype of competition of 0.03. Vaxcyte is anticipated to decline in value after the next headline, with the price expected to drop to 93.75. The average volatility of media hype impact on the company price is about 82.46%. The price decrease on the next news is expected to be -0.63%, whereas the daily expected return is at this time at -0.22%. The volatility of related hype on Vaxcyte is about 1550.88%, with the expected price after the next announcement by competition of 94.37. About 100.0% of the company shares are owned by institutional investors. The book value of Vaxcyte was at this time reported as 27.47. The company recorded a loss per share of 4.6. Vaxcyte had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out Vaxcyte Basic Forecasting Models to cross-verify your projections.Vaxcyte Related Hype Analysis
Having access to credible news sources related to Vaxcyte's direct competition is more important than ever and may enhance your ability to predict Vaxcyte's future price movements. Getting to know how Vaxcyte's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Vaxcyte may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TFFP | Tff Pharmaceuticals | (0.13) | 4 per month | 0.00 | (0.13) | 11.28 | (12.99) | 95.77 | |
| ELYM | Eliem Therapeutics | 0.25 | 4 per month | 0.00 | (0.19) | 6.21 | (9.35) | 34.87 | |
| INBX | Inhibrx | 1.00 | 6 per month | 2.72 | 0.01 | 5.54 | (6.11) | 16.80 | |
| ELVN | Enliven Therapeutics | (0.55) | 9 per month | 2.18 | 0.01 | 5.84 | (4.07) | 12.96 |
Vaxcyte Additional Predictive Modules
Most predictive techniques to examine Vaxcyte price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vaxcyte using various technical indicators. When you analyze Vaxcyte charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Vaxcyte Predictive Indicators
The successful prediction of Vaxcyte stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Vaxcyte, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Vaxcyte based on analysis of Vaxcyte hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Vaxcyte's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Vaxcyte's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 8.93 | 23.26 | 7.54 | 8.24 | Net Debt To EBITDA | 0.53 | 3.81 | 0.79 | 0.75 |
Story Coverage note for Vaxcyte
The number of cover stories for Vaxcyte depends on current market conditions and Vaxcyte's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vaxcyte is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vaxcyte's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Vaxcyte Short Properties
Vaxcyte's future price predictability will typically decrease when Vaxcyte's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vaxcyte often depends not only on the future outlook of the potential Vaxcyte's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vaxcyte's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 97.2 M | |
| Cash And Short Term Investments | 1.1 B |
Additional Tools for Vaxcyte Stock Analysis
When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.